Intelligence Platform
Patents
Browse 3,501 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8748632
Positive allosteric modulators of group II mGluRs
granted patentUS 8748601
Selective serine/threonine kinase inhibitors
granted patentUS 8748408
Methods of treatment of mitochondrial disorders
granted patentUS 8748176
Generation of choroid plexus epithelial cells from human embryonic stem cells
granted patentUS 8741589
Monitoring two dimensions of diabetes pathogenesis
granted patentUS 8741306
Kidney specific tumor vaccine directed against kidney tumor antigen G-250
granted patentUS 8735057
Fluorescence detection of poison oak oil
granted patentUS 8734799
Unconjugated anti-TfR antibodies and compositions thereof for the treatment of cancer
granted patentUS 8729088
Toll-like receptor modulators and treatment of diseases
granted patentUS 8728458
Combination anti-HIV vectors, targeting vectors, and methods of use
granted patentUS 8728757
Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (
granted patentUS 8729039
Use of inhibitory oligonucleotides to treat autoimmune disease
granted patentUS 8722896
Prokineticin receptor antagonists and uses thereof
granted patentUS 8716246
Azuvirin peptides
granted patentUS 8715653
Modulation of Rhamm (CD168) for selective adipose tissue development
granted patentUS 8710030
Phosphonate compounds
granted patentUS 8709452
Synthetic bone grafts
granted patentUS 8703751
Androstenediol as an indicator for assessing estrogenicity
granted patentUS 8703920
Fully human antibodies against N-cadherin
granted patentUS 8697836
Composition and method for inducing and enhancing a telomerase reverse transcriptase-react
granted patentUS 8697079
IgE antibodies for the treatment of cancer
granted patentUS 8697082
Prevention and treatment of synucleinopathic and amyloidogenic disease
granted patentUS 8697348
Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
granted patentUS 8697709
Fused ring heteroaryl kinase inhibitors
granted